Thread by @Equity4Life_

A thread on key takeaways from #BalajiAmines Annual Report-2022.

Courtesy @ash_lodha

👉Business blueprint since beginning:

1) Focus on import substitute products.
2) Use local technology to develop & manufacture products.
3) Alter design & processes to make products cost effective.

👉Largest Indian producer of the following products:

• Methylamines
• Ethylamines
• Di-Methyl Acetamide (DMAC)
• Di-Methyl Amine Hydrochloride (DMA HCL)
• Dimethylformamide (DMF)

👉Sole Manufacturer in India for the following products:

• Morpholine
• Dimethylformamide (DMF)
• N-Ethyl-2-Pyrrolidone (NEP)
• N-Methyl-Pyrrolidone (NMP)
• Pharmapure Povidone
• Pharmapure Povidone (PVP K30 & PVP K25)
• Gamma Butyrolactone (GBL)

👉Competitive Advantage:

• Fully Automated plants controlled through DCS System.
• Only company to use indigenous technology to manufacture amines & allied products.
• Global presence in > 50 countries & > 1200 customers
• All facilities are zero liquid discharge units.

👉Product wise Performance

👉Key Numbers:

👉Key Ratio’s:

👉Takeaway from Chairman's Speech:

👉Capex Blueprint:

👉Management Discussion & Analysis

👉Management Discussion & Analysis

📝Balaji Specialty Chemical Ltd (BSCL)- subsidiary of Balaji Amines Ltd:

👉Financial performance of Balaji Specialty Chemical Ltd (BSCL).